首頁 > 市場調查報告書 > 製藥

開發平台分析

市場調查報告書

商品編碼

1098610

Friedreich運動失調的市場規模、佔有率、展望、機會 (2022年～2030年):各藥物類別 (ACE抑制劑、β隔斷劑、利尿劑、對苯醌、其他)、給藥途徑、通路、地區

Friedreich's Ataxia Market, by Drug Class (ACE Inhibitors, Beta Blockers, Diuretics, Para-Benzoquinone, and Others ), by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年06月07日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

Friedreich運動失調的高醫療負擔，技術的進步，主要企業的M&A和聯盟等無機性成長策略的採用等要素在預測期間內促進全球Friedreich運動失調市場成長。

本報告提供全球Friedreich運動失調的市場調查，市場定義和概要，市場成長的各種影響因素分析，法律規章、償付環境，開發平台的分析，市場規模的變化、預測，各種區分、各地區/主要國家的明細，競爭環境，主要企業簡介等彙整資訊。

熱圖分析
市場佔有率分析
- Reata Pharmaceuticals, Inc.
- Retrotope Inc.
- Minoryx
- PTC Therapeutics
- Design Therapeutics, Inc.
- Larimar Therapeutics, Inc.
- Jupiter Neurosciences, Inc.
- Lexeo Therapeutics
- Zydus Lifesciences Ltd.
- Cipla Limited
- GlaxoSmithKline Plc.
- Aurobindo Pharma Ltd.
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
分析師的見解

第10章 Section

簡介目錄

Product Code: CMI5034

Ataxia refers to a group of degenerative neurological diseases that affect coordination and movement center of the brain (cerebellum). People suffering from ataxia have difficulty in swallowing, speech, and maintaining balance or coordination. Ataxia can be of several types such as spinocerebellar ataxia, Friedreich's ataxia, ataxia-telangiectasia, multiple system atrophy (MSA), episodic ataxia, and others. Friedreich's ataxia can develop at any age and is progressive in nature i.e. it worsens with time. Friedreich's ataxia (FA) is a genetic ataxia that is caused when a damaged gene which leads to FA is passed from one generation to the other. In addition to common movement related symptoms, people suffering from Friedreich's ataxia also experience symptoms such as stiffness and loss of sensation in muscles, weakness in the body, heart condition (hypertrophic cardiomyopathy), and others.

Market Dynamics

High burden of Friedreich's ataxia, rising technological advancements, and increasing adoption of inorganic growth strategies such as acquisitions, mergers, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global Friedreich's ataxia market over the forecast period.

For instance, according to a review article published by the Frontiers in Neuroscience journal, a peer-reviewed open access scientific journal, in February 2022, it was estimated that the prevalence of Friedreich ataxia was 1:50,000 individuals, around the globe as of 2021

Moreover, in February 2019, the University of Oxford, England and Harrington Discovery Institute at University Hospitals in Ohio, U.S. announced a global partnership to address unmet need of patients suffering from rare diseases such as muscular dystrophy, cystic fibrosis, ataxia, and others

Key features of the study:

This report provides an in-depth analysis of the global Friedreich's ataxia market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new Material launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Friedreich's ataxia market based on the following parameters - company overview, financial performance, Material portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Reata Pharmaceuticals, Inc., Retrotope Inc., Minoryx, PTC Therapeutics, Design Therapeutics, Inc., Larimar Therapeutics, Inc., Jupiter Neurosciences, Inc., Lexeo Therapeutics, Zydus Lifesciences Ltd., Cipla Limited, GlaxoSmithKline Plc., Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Intas Pharmaceuticals Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future Material launches, type up-gradation, market expansion, and marketing tactics
The global Friedreich's ataxia market report caters to various stakeholders in this industry including investors, suppliers, Material manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Friedreich's ataxia market

Detailed Segmentation:

Global Friedreich's Ataxia Market, By Drug Class:
- ACE Inhibitors
- Beta Blockers
- Diuretics
- Para-Benzoquinone
- Others (Vitamin E, immunomodulators, skeletal muscle relaxants, and anti-epileptic drugs, among others)
Global Friedreich's Ataxia Market, By Route of Administration:
- Oral
- Injectable
Global Friedreich's Ataxia Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Friedreich's Ataxia Market, By Region:
- North America
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Country/Region
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Reata Pharmaceuticals, Inc.*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Retrotope Inc.
- Minoryx
- PTC Therapeutics
- Design Therapeutics, Inc.
- Larimar Therapeutics, Inc.
- Jupiter Neurosciences, Inc.
- Lexeo Therapeutics
- Zydus Lifesciences Ltd.
- Cipla Limited
- GlaxoSmithKline Plc.
- Aurobindo Pharma Ltd.
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Reimbursement Scenario
Mergers & Acquisitions

4. Global Friedreich's Ataxia Market - Impact of Coronavirus (Covid-19) Pandemic

COVID 19 Epidemiology
Demand and Supply Chain Analysis

5. Global Friedreich's Ataxia Market, By Drug Class, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
ACE Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Beta Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Para-Benzoquinone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others (Vitamin E, Immunomodulators, Skeletal Muscle Relaxants, and Anti-Epileptic Drugs, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Friedreich's Ataxia Market, By Route of Administration, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Friedreich's Ataxia Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Friedreich's Ataxia Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
North America
- Market Size and Forecast, By Drug Class, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug Class, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Class, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Reata Pharmaceuticals, Inc.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Retrotope Inc.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Minoryx
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PTC Therapeutics
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Design Therapeutics, Inc.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Larimar Therapeutics, Inc.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Jupiter Neurosciences, Inc.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lexeo Therapeutics
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Zydus Lifesciences Ltd.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Limited
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma Ltd.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Torrent Pharmaceuticals Ltd.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Intas Pharmaceuticals Ltd.
- Company Overview
- Material Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Analyst Views

10. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

漸進式運動失調和肌無力症藥物的全球市場

FAQ

Friedreich運動失調的市場規模、佔有率、展望、機會 (2022年～2030年):各藥物類別 (ACE抑制劑、β隔斷劑、利尿劑、對苯醌、其他)、給藥途徑、通路、地區

Friedreich's Ataxia Market, by Drug Class (ACE Inhibitors, Beta Blockers, Diuretics, Para-Benzoquinone, and Others ), by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目錄

第1章調查目的、前提條件

第2章市場概要

第3章市場動態、法規、趨勢分析

第4章全球Friedreich運動失調市場:COVID-19影響

第5章全球Friedreich運動失調市場:各類藥物

第6章全球Friedreich運動失調市場:各給藥途徑

第7章全球Friedreich運動失調市場:各銷售管道

第8章全球Friedreich運動失調市場:各地區

第9章競爭情形

第10章 Section

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Friedreich's Ataxia Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Friedreich's Ataxia Market, By Drug Class, 2017 - 2030, (US$ Mn)

6. Global Friedreich's Ataxia Market, By Route of Administration, 2017 - 2030, (US$ Mn)

7. Global Friedreich's Ataxia Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

8. Global Friedreich's Ataxia Market, By Region, 2017 - 2030, (US$ Mn)

9. Competitive Landscape

10. Section

Friedreich運動失調的市場規模、佔有率、展望、機會 (2022年～2030年):各藥物類別 (ACE抑制劑、β隔斷劑、利尿劑、對苯醌、其他)、給藥途徑、通路、地區

Friedreich's Ataxia Market, by Drug Class (ACE Inhibitors, Beta Blockers, Diuretics, Para-Benzoquinone, and Others ), by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目錄

第1章 調查目的、前提條件

第2章 市場概要

第3章 市場動態、法規、趨勢分析

第4章 全球Friedreich運動失調市場:COVID-19影響

第5章 全球Friedreich運動失調市場:各類藥物

第6章 全球Friedreich運動失調市場:各給藥途徑

第7章 全球Friedreich運動失調市場:各銷售管道

第8章 全球Friedreich運動失調市場:各地區

第9章 競爭情形

第10章 Section

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Friedreich's Ataxia Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Friedreich's Ataxia Market, By Drug Class, 2017 - 2030, (US$ Mn)

6. Global Friedreich's Ataxia Market, By Route of Administration, 2017 - 2030, (US$ Mn)

7. Global Friedreich's Ataxia Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

8. Global Friedreich's Ataxia Market, By Region, 2017 - 2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章調查目的、前提條件

第2章市場概要

第3章市場動態、法規、趨勢分析

第4章全球Friedreich運動失調市場:COVID-19影響

第5章全球Friedreich運動失調市場:各類藥物

第6章全球Friedreich運動失調市場:各給藥途徑

第7章全球Friedreich運動失調市場:各銷售管道

第8章全球Friedreich運動失調市場:各地區

第9章競爭情形